SS
RCEL icon

SBI Securities’s Avita Medical RCEL Stock Holding History

SBI Securities’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22K Hold
295
– – ﹤0.01% 2726
2026
Q1 		$1.09K Sell
295
-8
-3% -$34 ﹤0.01% 2625
2025
Q4 		$1.04K Buy
303
+106
+54% +$423 ﹤0.01% 2631
2025
Q3 		$1.01K Sell
197
-48
-20% -$250 ﹤0.01% 2690
2025
Q2 		$1.3K Sell
245
-1
-0.4% -$7 ﹤0.01% 2565
2025
Q1 		$2K Sell
246
-22
-8% -$206 ﹤0.01% 2289
2024
Q4 		$3.43K Buy
+268
New +$3.16K ﹤0.01% 2071

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SBI Securities's RCEL Position: Q2 2026 in Review

SBI Securities held its Avita Medical (RCEL) position steady in Q2 2026 at 295 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2726.

SBI Securities first reported a position in RCEL in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.43K in Q4 2024. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • SBI Securities held 295 shares of Avita Medical worth $1.22K as of Q2 2026.
  • SBI Securities left its Avita Medical share count unchanged in Q2 2026.
  • Avita Medical made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2726 holding.
  • SBI Securities first reported a position in Avita Medical in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Avita Medical position peaked at $3.43K in Q4 2024.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.